Literature DB >> 29115889

Circulating fetal and total cell-free DNA, and sHLA-G in black South African women with gestational hypertension and pre-eclampsia.

Simeon Eche1, Irene Mackraj1, Jagidesa Moodley2.   

Abstract

OBJECTIVE: Quantification of circulating fetal and total cell-free DNA (cfDNA) and soluble human leucocyte antigen (HLAG) in gestational hypertension and pre-eclampsia.
METHODS: Serum cfDNA were quantified in controls, pre-eclamptics, and gestational hypertensive patients using real-time qPCR. Soluble HLAG was measured by enzyme-linked immune-sorbent assay.
RESULTS: Serum fetal and total cfDNA levels were higher in pre-eclampsia compared with the controls and gestational hypertensives (p < 0.001), more so in severe compared with mild-to-moderate pre-eclampsia (p < 0.05). Soluble HLAG levels were lower in pre-eclamptics than controls and gestational hypertension (p < 0.05).
CONCLUSION: Circulating fetal and total cfDNA were increased, while soluble HLAG was decreased in pre-eclampsia.

Entities:  

Keywords:  Fetal cell-free DNA; gestational hypertension; pre-eclampsia; soluble human leucocyte antigen; total cell-free DNA

Mesh:

Substances:

Year:  2017        PMID: 29115889     DOI: 10.1080/10641955.2017.1385794

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  9 in total

1.  Dynamic Changes of Fetal-Derived Hypermethylated RASSF1A and Septin 9 Sequences in Maternal Plasma.

Authors:  Li Zhang; Chen-Mei-Yi Wang; Wei-Ping Zhou; Qiu-Ping Chen; Shuai Zhou; Wen Lei; Hua Deng; Liang Zhang; Guo-Cheng Liu
Journal:  Reprod Sci       Date:  2021-01-08       Impact factor: 3.060

2.  Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction.

Authors:  Danila Morano; Stefania Rossi; Cristina Lapucci; Maria Carla Pittalis; Antonio Farina
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

Review 3.  Uterine Natural Killer Cells: A Rising Star in Human Pregnancy Regulation.

Authors:  Min Xie; Yan Li; Yi-Zi Meng; Peng Xu; Yong-Guang Yang; Shuai Dong; Jin He; Zheng Hu
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

4.  Assessment of plasma cell-free DNA and ST2 as parameters in gestational hypertension and preeclampsia.

Authors:  Lisheng Liu; Hua Li; Ning Wang; Xingguo Song; Ke Zhao; Cong Zhang
Journal:  Hypertens Res       Date:  2021-04-16       Impact factor: 3.872

5.  Cell-free DNA as a potential biomarker for preeclampsia.

Authors:  Ana C Palei
Journal:  Expert Rev Mol Diagn       Date:  2021-10-29       Impact factor: 5.225

6.  HLA-G Polymorphisms Associated with HIV Infection and Preeclampsia in South Africans of African Ancestry.

Authors:  Wendy N Phoswa; Veron Ramsuran; Thajasvarie Naicker; Ravesh Singh; Jagidesa Moodley
Journal:  Biomed Res Int       Date:  2020-06-10       Impact factor: 3.411

7.  The Roles of Uterine Natural Killer (NK) Cells and KIR/HLA-C Combination in the Development of Preeclampsia: A Systematic Review.

Authors:  Xiuhua Yang; Yahui Yang; Yiru Yuan; Lin Liu; Tao Meng
Journal:  Biomed Res Int       Date:  2020-03-28       Impact factor: 3.411

Review 8.  Role of the NLRP3 Inflammasome in Preeclampsia.

Authors:  Koumei Shirasuna; Tadayoshi Karasawa; Masafumi Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-25       Impact factor: 5.555

9.  Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes.

Authors:  Lorena M Amaral; Valeria C Sandrim; Matthew E Kutcher; Frank T Spradley; Ricardo C Cavalli; Jose E Tanus-Santos; Ana C Palei
Journal:  Int J Mol Sci       Date:  2021-01-08       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.